Article info

Download PDFPDF

Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

Authors

  • Zachary J. Brown Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Bernd Heinrich Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Seth M. Steinberg Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Su Jong Yu Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  • Tim F. Greten Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health 20892 Bethesda MD USA PubMed articlesGoogle scholar articles
  1. a zachary.brown{at}nih.gov
  2. b bernd.heinrich{at}nih.gov
  3. c steinbes{at}mail.nih.gov
  4. d sujong.yu{at}nih.gov
  5. e tim.greten{at}nih.gov
View Full Text

Citation

Brown ZJ, Heinrich B, Steinberg SM, et al
Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer

Publication history

  • Received May 15, 2017
  • Accepted October 27, 2017
  • First published November 21, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.